Concepedia

Chiaki Tsuge Ishida

CT

Statistics

Publications

9

Citations

415

H-Index

9

Active since

2017

Affiliations

Columbia University Irving Medical Center(Current)

Universität Ulm

City University of New York

Bronx Community College

University Hospital Ulm

Chiaki Tsuge Ishida is an author at Columbia University Irving Medical Center specializing in oncology, molecular oncology, and pharmacology.

Publications per year

2017–2019

9

Publications

9

Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL

Georg Karpel‐Massler, Chiaki Tsuge Ishida, Elena Bianchetti et al. · Nature Communications · 2017 · 114 citations · Full text

, , +17

Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses

Georg Karpel‐Massler, Chiaki Tsuge Ishida, Elena Bianchetti et al. · Cancer Research · 2017 · 75 citations · Full text

, , +14

Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma

Yiru Zhang, Chiaki Tsuge Ishida, Wataru Ishida et al. · Clinical Cancer Research · 2018 · 50 citations · Full text

, , +17

Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl‐xL inhibition

Trang Nguyen, Chiaki Tsuge Ishida, Enyuan Shang et al. · EMBO Molecular Medicine · 2019 · 49 citations · Full text

, , +14

BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma

Chiaki Tsuge Ishida, Elena Bianchetti, Chang Shu et al. · Oncotarget · 2017 · 42 citations · Full text

, , +13

1–5 of 9